SEMA4 HOLDINGS INVESTOR ALERT - Kuznicki Law PLLC Investigates Sema4 Holdings Corp. - SMFR
March 10 2022 - 5:36PM
Business Wire
Kuznicki Law PLLC is investigating the proposed sale of GeneDx,
Inc. to Sema4 Holdings Corp. (“the Company”) (NasdaqGS: SMFR).
Under the terms of the proposed transaction, Sema4 will acquire
GeneDx for a total upfront consideration of approximately $473
million, and a total aggregate consideration including potential
milestones of approximately $623 million, based on the closing
stock price of Sema4 as of January 14, 2022. Kuznicki Law is
seeking to determine whether the merger and the process that led to
it are adequate and fair to the Company’s shareholders.
If you would like to discuss your legal rights regarding the
proposed sale, you may, without obligation or cost to you, contact
us toll free at 833-938-0905, via email (dk@kclasslaw.com), or
visit https://kclasslaw.com/cases/ma/nasdaqgs-smfr/ to learn
more.
Kuznicki Law PLLC is committed to ensuring that companies adhere
to responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a Company lead to artificial
inflation of the Company’s stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220310006016/en/
Kuznicki Law PLLC Daniel Kuznicki, Esq. Email: dk@kclasslaw.com
Phone: (347) 696-1134 Cell: (347) 690-0692 Fax: (347) 348-0967
https://kclasslaw.com
Sema4 (NASDAQ:SMFR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sema4 (NASDAQ:SMFR)
Historical Stock Chart
From Apr 2023 to Apr 2024